Minimization of sample size when comparing two small probabilities in a non‐inferiority safety trial
- 18 May 2004
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 23 (11) , 1683-1699
- https://doi.org/10.1002/sim.1760
Abstract
In clinical trials success rates of two treatments to be compared often range from 10 to 90 per cent. When the comparison probabilities are (much) smaller than 10 per cent, standard methods for sample size and power calculations may provide invalid results. This situation may occur when there is interest in safety rather than in efficacy. In such trials, no more patients should be included than strictly necessary. We compared the results of maximum likelihood methods for the computation of sample sizes in a non‐inferiority trial, including exact procedures and considered unequal sample sizes for experimental and reference treatment. An exact, unequal sample size maximum likelihood procedure is advocated when the specified non‐zero risk difference under the null hypothesis is not too large. Such a procedure is also indicated when the parameter of interest is the relative risk, rather than the risk difference. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Sample size tables for exact single‐stage phase II designsStatistics in Medicine, 2001
- Optimal three-stage designs for phase II cancer clinical trialsStatistics in Medicine, 1997
- Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilitiesStatistics in Medicine, 1995
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Comparative analysis of two ratesStatistics in Medicine, 1985
- Optimal Allocation for the Comparison of ProportionsPublished by JSTOR ,1982
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982